Royal Bank of Canada
AIMT

Royal Bank of Canada’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-61,571
Closed -$2.12M 6885
2020
Q3
$2.12M Sell
61,571
-94,353
-61% -$3.25M ﹤0.01% 2295
2020
Q2
$2.61M Sell
155,924
-1,378
-0.9% -$23K ﹤0.01% 2116
2020
Q1
$2.27M Sell
157,302
-7,031
-4% -$101K ﹤0.01% 2063
2019
Q4
$5.5M Sell
164,333
-5,223
-3% -$175K ﹤0.01% 1753
2019
Q3
$3.55M Buy
169,556
+39,778
+31% +$833K ﹤0.01% 1950
2019
Q2
$2.7M Buy
129,778
+12,099
+10% +$252K ﹤0.01% 2127
2019
Q1
$2.63M Buy
117,679
+29,963
+34% +$670K ﹤0.01% 2092
2018
Q4
$2.1M Buy
87,716
+9,939
+13% +$238K ﹤0.01% 2146
2018
Q3
$2.12M Buy
77,777
+59,901
+335% +$1.63M ﹤0.01% 2339
2018
Q2
$480K Buy
17,876
+413
+2% +$11.1K ﹤0.01% 3279
2018
Q1
$555K Buy
17,463
+17,076
+4,412% +$543K ﹤0.01% 3075
2017
Q4
$15K Sell
387
-2,882
-88% -$112K ﹤0.01% 4967
2017
Q3
$81K Buy
3,269
+3,190
+4,038% +$79K ﹤0.01% 4425
2017
Q2
$1K Sell
79
-747
-90% -$9.46K ﹤0.01% 5720
2017
Q1
$19K Sell
826
-1,373
-62% -$31.6K ﹤0.01% 4986
2016
Q4
$45K Buy
2,199
+2,117
+2,582% +$43.3K ﹤0.01% 4576
2016
Q3
$1K Buy
+82
New +$1K ﹤0.01% 5566
2016
Q1
Sell
-20
Closed 5883
2015
Q4
$0 Sell
20
-380
-95% ﹤0.01% 6103
2015
Q3
$10K Buy
+400
New +$10K ﹤0.01% 5303